Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVRP.L Share News (VRP)

  • There is currently no data for VRP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

SABMilller Chairman sells over 11m pounds in shares

Tue, 23rd Jul 2013 16:21

Graham Mackay, the Chairman of SABMiller who is currently on a medical leave of absence due to a brain tumour, has sold over 11m pounds-worth of shares in the company.Mackay sold a total of 350,000 shares between July 16-18th through three separate transactions, the firm revealed on Tuesday. He sold: 138,000 at 3,266.8p each; 50,000 at 3,250.74p each; and another 162,000 at 3,251.4p each.He pocketed £11.4m through the sale, leaving his holding at just over 1.4m shares.The director first joined the beverages company back in 1978 when it was known as South African Breweries and was its Chief Executive Officer (CEO) at the time of its listing in London in 1999. The company was renamed to SABMiller following the purchase of US group Miller Brewing Company in 2002.Mackay was appointed Executive Chairman in July 2012 but, after being diagnosed with a brain tumour in April, the firm accelerated the promotion of Alan Clark to CEO with Mackay taking a more back-seat position of Non-Executive Chairman. At the time of Clark's appointment, the company said it would keep Mackay's position under review until the outcome of his treatment following surgery in April.SABMiller's share price has increased by nearly 16% since the start of 2013.Top Director BuysVerona Pharma (VRP) Director name: Mr Stuart BottomlyAmount purchased: 3,000,000 @ 1.67p Value: £50,100Scancell Holdings (SCLP) Director name: Ms Katherine Cornish-BowdenAmount purchased: 45,000 @ 32.00p Value: £14,400Top Director SellsSABMiller (SAB) Director name: Mr Graham MackayAmount sold: 162,000 @ 3,251.40p Value: £5,267,268SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 138,000 @ 3,266.80p Value: £4,508,184SABMiller (SAB) Director name: Mr Graham MackayAmount sold: 50,000 @ 3,250.74p Value: £1,625,370Accsys Technologies (AXS) Director name: Mr Paul Hugh Anthony Clegg Amount sold: 1,500,000 @ € 0.14 Value: € 204,000Accsys Technologies (AXS) Director name: Mr Hans Pauli Amount sold: 330,000 @ € 0.14 Value: € 44,880Accsys Technologies (AXS) Director name: Mr William Bickerton RudgeAmount sold: 119,686 @ € 0.14 Value: € 16,277BC
More News
5 Nov 2015 10:50

Verona Pharma Completes Patient Enrolment For RPL554 Studies

Read more
14 Oct 2015 10:40

Verona Pharma: First Patients Dosed In RPL554 Combination Study

Read more
29 Sep 2015 09:18

Verona Pharma rallies on positive drug study results

(ShareCast News) - Shares in Verona Pharma rallied after it announced positive headline data from the third and final part of a clinical study on its RPL554 drug for the treatment of chronic obstructive pulmonary disease. The drug development company said the primary objective of this part of the st

Read more
29 Sep 2015 07:58

Verona Pharma Shares Up 10% On Good RPL554 Study Results

Read more
8 Sep 2015 08:28

Verona Pharma plunges as interim loss widens

(ShareCast News) - Shares in Verona Pharma plunged over 12% early on Tuesday, after the pharmaceutical company posted a wider interim pre-tax loss. The London-listed company, which attributed the wider loss to an increase in research and development spending, saw its pre-tax loss for the six months

Read more
8 Sep 2015 07:23

Verona Pharma Loss Widens On Higher Research And Development Spending

Read more
12 Jun 2015 11:19

LONDON MIDDAY BRIEFING: Greece Remains Optimistic For Debt Deal

Read more
12 Jun 2015 10:27

WINNERS & LOSERS: Petra Diamonds Loses Sparkle On Lower Quality Stones

Read more
12 Jun 2015 09:46

Verona Pharma to launch secondary listing in Germany

AIM-listed drug developer Verona Pharma has carried out a second listing in Germany. The move will be a way of further raising its profile within continental Europe and to increase the potential for investors in German-speaking Europe to trade in the company's shares, it said. The group will be lis

Read more
12 Jun 2015 08:40

Verona Pharma Takes Secondary Listing In Germany (ALLISS)

Read more
11 Jun 2015 07:52

Verona Pharma Begins Phase 2A Dose-Finding Trial Of RPL554 In Asthma

Read more
11 Jun 2015 07:32

LONDON MORNING BRIEFING: Royal Mail Falls, RBS Gains On UK Govt Moves

Read more
11 Jun 2015 05:26

AGM, EGM Calendar - Week Ahead

Read more
10 Jun 2015 15:00

AGM, EGM Calendar - Week Ahead

Read more
10 Jun 2015 05:30

AGM, EGM Calendar - Week Ahead

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.